Tate & Lyle acquires Swedish oat beta glucan business

Posted: 20 May 2013 | Tate & Lyle | No comments yet

Tate & Lyle has acquired Biovelop, a Swedish manufacturer of oat beta glucan…

Tate and Lyle logo

Tate & Lyle PLC (“Tate & Lyle”), a leading global provider of speciality food ingredients and solutions, announces that it has acquired Biovelop, a Swedish manufacturer of oat beta glucan.

Operating from a production facility in Kimstad, Sweden, Biovelop produces oat beta glucan under the brand name PromOat™ for use in the food, beverage and supplement markets, and under the brand name Avenacare™ for use in the cosmetics industry. In addition, it produces a range of other oat-based ingredients including PrOATein™ (oat protein), oat dextrin and insoluble oat fibre. Biovelop’s products are manufactured from non-GMO oats sourced from within Sweden using a chemical-free process.

Beta glucan is a soluble fibre which has widely approved health claims, including EFSA, for lowering cholesterol and reducing post prandial glycaemic response.

Biovelop is a relatively early-stage business having been founded in 2005 and made its first sale of commercial product in 2010.

Olivier Rigaud, President, Speciality Food Ingredients for Tate & Lyle said: “We are delighted to welcome the Biovelop business and its employees to Tate & Lyle. The addition of Biovelop’s soluble oat beta glucan, supported by strong scientific health claims, represents an excellent addition to Tate & Lyle’s existing fibres and health and wellness portfolios.”

Related organisations

Related people